Biologic Excipients Market Is Projected to Reach US$ 1,706.2 Million by 2028
Revenue from the biologic excipients market in North America is expected to expand at relatively higher CAGR due to growing adoption of advanced drug delivery technologies coupled with rising global demand for medicines.
View full press release